193 related articles for article (PubMed ID: 12145328)
1. The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane.
Garrigues A; Escargueil AE; Orlowski S
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10347-52. PubMed ID: 12145328
[TBL] [Abstract][Full Text] [Related]
2. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
Gayet L; Dayan G; Barakat S; Labialle S; Michaud M; Cogne S; Mazane A; Coleman AW; Rigal D; Baggetto LG
Biochemistry; 2005 Mar; 44(11):4499-509. PubMed ID: 15766280
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux.
Tainton KM; Smyth MJ; Jackson JT; Tanner JE; Cerruti L; Jane SM; Darcy PK; Johnstone RW
Cell Death Differ; 2004 Sep; 11(9):1028-37. PubMed ID: 15131592
[TBL] [Abstract][Full Text] [Related]
4. A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein.
Garrigues A; Nugier J; Orlowski S; Ezan E
Anal Biochem; 2002 Jun; 305(1):106-14. PubMed ID: 12018951
[TBL] [Abstract][Full Text] [Related]
5. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
He L; Liu GQ
Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192
[TBL] [Abstract][Full Text] [Related]
6. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.
Ramachandra M; Ambudkar SV; Chen D; Hrycyna CA; Dey S; Gottesman MM; Pastan I
Biochemistry; 1998 Apr; 37(14):5010-9. PubMed ID: 9538020
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance protein 1 is not associated to detergent-resistant membranes.
Cerf E; Gasper R; Belani JD; Rychnovsky S; Chang XB; Buyse F; Ruysschaert JM
Biochem Biophys Res Commun; 2007 Apr; 355(4):1025-30. PubMed ID: 17336270
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine modulates P-glycoprotein function.
Orlowski S; Valente D; Garrigos M; Ezan E
Biochem Biophys Res Commun; 1998 Mar; 244(2):481-8. PubMed ID: 9514944
[TBL] [Abstract][Full Text] [Related]
9. First characterization of fish P-glycoprotein (abcb1) substrate specificity using determinations of its ATPase activity and calcein-AM assay with PLHC-1/dox cell line.
Zaja R; Lončar J; Popovic M; Smital T
Aquat Toxicol; 2011 May; 103(1-2):53-62. PubMed ID: 21392495
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol interaction with the daunorubicin binding site of P-glycoprotein.
Wang E; Casciano CN; Clement RP; Johnson WW
Biochem Biophys Res Commun; 2000 Oct; 276(3):909-16. PubMed ID: 11027568
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells.
Chen Y; Pant AC; Simon SM
Cancer Res; 2001 Nov; 61(21):7763-9. PubMed ID: 11691790
[TBL] [Abstract][Full Text] [Related]
12. Interaction of CJZ3, a lomerizine derivative, with ATPase activity of human P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Ji BS; Li M; He L
Pharmazie; 2010 Jul; 65(7):515-9. PubMed ID: 20662321
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein does not actively transport nicotine and cotinine.
Wang JS; Markowitz JS; Donovan JL; Devane CL
Addict Biol; 2005 Jun; 10(2):127-9. PubMed ID: 16191663
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein senses its substrates and the lateral membrane packing density: consequences for the catalytic cycle.
Aänismaa P; Gatlik-Landwojtowicz E; Seelig A
Biochemistry; 2008 Sep; 47(38):10197-207. PubMed ID: 18759452
[TBL] [Abstract][Full Text] [Related]
15. Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles.
Garrigos M; Belehradek J; Mir LM; Orlowski S
Biochem Biophys Res Commun; 1993 Nov; 196(3):1034-41. PubMed ID: 7902705
[TBL] [Abstract][Full Text] [Related]
16. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant cancer cells contain two populations of P-glycoprotein with differently stimulated P-gp ATPase activities: evidence from atomic force microscopy and biochemical analysis.
Barakat S; Gayet L; Dayan G; Labialle S; Lazar A; Oleinikov V; Coleman AW; Baggetto LG
Biochem J; 2005 Jun; 388(Pt 2):563-71. PubMed ID: 15693753
[TBL] [Abstract][Full Text] [Related]
18. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.
Shu Y; Liu H
Biochem Cell Biol; 2007 Oct; 85(5):638-46. PubMed ID: 17901905
[TBL] [Abstract][Full Text] [Related]
19. ATP occlusion by P-glycoprotein as a surrogate measure for drug coupling.
Tombline G; Holt JJ; Gannon MK; Donnelly DJ; Wetzel B; Sawada GA; Raub TJ; Detty MR
Biochemistry; 2008 Mar; 47(10):3294-307. PubMed ID: 18275155
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
Eckford PD; Sharom FJ
Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]